A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease)
Clinical trial NCT05418101 · COMPLETED
Trial details
- NCT number
- NCT05418101
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2024-03-13
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.